Product Reports Resources Pricing Login Book a demo

Eris Lifesciences

Biotech & Life Sciences · Ahmedabad, India · Founded 2007 · IPO 2017

Domestic pharmaceutical company focused on a wide range of products in the chronic and acute therapy segments

Valuation $2.87B
Revenue $423M
EBITDA $153M

Talent graph

Eris Lifesciences's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

1 investor on Eris Lifesciences's cap table

Sourced from Dealroom's funding and investor records.

Series B+ 1 investor entered at this stage
Chrys Capital

Global footprint

Where Eris Lifesciences has talent and traffic

Workforce by country
12 countries with
team presence
🇮🇳 India98.6%
🇦🇪 United Arab Emirates0.4%
🇬🇧 United Kingdom0.3%
🇺🇸 United States0.1%
🇦🇺 Australia0.1%
Top 5 of 12 shown
Web traffic by country
13K monthly visits
across markets
🇮🇳 India103.1%
Top 1 markets shown

Capital deployed

Eris Lifesciences's 4 investments and acquisitions.

Every disclosed deal where Eris Lifesciences appeared as a backer or acquirer, 2017–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Eris Lifesciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Eris Lifesciences's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        What the market is saying about Eris Lifesciences

        An AI-synthesized read of the highest-engagement posts about Eris Lifesciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Eris Lifesciences on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.